Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $814.1000 (2.07%) ($814.1000 - $814.1000) on Fri. Aug. 18, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.71% (three month average) | RSI | 79 | Latest Price | $814.1000(2.07%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.2% a day on average for past five trading days. | Weekly Trend | REGN advances 3.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) XLV(61%) IBB(59%) DIA(47%) XLF(47%) SPY(45%) | Factors Impacting REGN price | REGN will decline at least -0.855% in a week (0% probabilities). VXX(-44%) VIXM(-40%) USO(-14%) TBT(-12%) GLD(-5%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.855% (StdDev 1.71%) | Hourly BBV | 2.8 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $804.66(1.17%) | 10 Day Moving Average | $796.92(2.16%) | 20 Day Moving Average | $771.36(5.54%) | To recent high | 0% | To recent low | 17.6% | Market Cap | $86.318b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |